Financials
Financial year 2025
Ajoint Rheumatology from Aalst, company number BE1014711852, closed financial year 2025 with a result of € 56,179 after tax. For that financial year Ajoint Rheumatology recorded a gross margin of € 71,105 and equity of € 56,820. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 22, 2026.
€ 56,820
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 56,179
Profit after tax over the fiscal year.
€ 69,959
Cash and bank balances on the last day of the fiscal year.
€ 859 paid out
2 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 2,481
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 750
Supplier invoices still open on the last day of the fiscal year.
€ 14,411
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Ask about Ajoint Rheumatology the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Ajoint Rheumatology?
What happened at Ajoint Rheumatology in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 56,179. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Aalst. KBO
- Charlotte Lievens became a director. NBB
In short
Paid € 14,411 in corporate taxes since 2025.
Paid out € 859 in dividends to the owners in total.
Management
Behind Ajoint Rheumatology is Charlotte Lievens.
Directors
According to the 2025 annual accounts
Charlotte Lievens
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Dendermondse steenweg 184
9300 Aalst
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Aalst
Same main activity (Activiteiten van medisch specialisten), 44 active companies in Aalst, largest first.
€ 2.8 million gross margin · 2025
€ 1.4 million gross margin · 2025
€ 953,115 gross margin · 2025
Dokter Joris Vander Mijnsbrugge, oftalmoloog
€ 843,721 gross margin · 2025
€ 762,446 gross margin · 2025
Dr. Jerrold SPAPEN, Cardiologie
€ 557,444 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- LIEVENS Charlotte(oprichter) 100%
Details
- Company number
- 1014.711.852
- VAT number
- BE 1014.711.852
- Registered office
- Dendermondse steenweg 184, 9300 Aalst
- Names & denominations
- Ajoint Rheumatology
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 October 2024
- Peppol
- Active · Active since 13 Dec 2024
- Activities · NACE
Activiteiten van medisch specialisten